0000899243-17-023946.txt : 20171010 0000899243-17-023946.hdr.sgml : 20171009 20171010161137 ACCESSION NUMBER: 0000899243-17-023946 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171009 FILED AS OF DATE: 20171010 DATE AS OF CHANGE: 20171010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gengos Andrew CENTRAL INDEX KEY: 0001563623 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37566 FILM NUMBER: 171130617 MAIL ADDRESS: STREET 1: 21900 BURBANK BOULEVARD STREET 2: 3RD FLOOR CITY: WOODLAND HILLS STATE: CA ZIP: 91367 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNLOGIC, INC. CENTRAL INDEX KEY: 0001527599 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261824804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 SIDNEY STREET STREET 2: SUITE 320 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-401-9975 MAIL ADDRESS: STREET 1: 200 SIDNEY STREET STREET 2: SUITE 320 CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Mirna Therapeutics, Inc. DATE OF NAME CHANGE: 20110809 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2017-10-09 1 0001527599 SYNLOGIC, INC. SYBX 0001563623 Gengos Andrew C/O SYNLOGIC, INC. 200 SIDNEY STREET, SUITE 320 CAMBRIDGE MA 02139 0 1 0 0 See Remarks Chief Operating Officer and Head of Corporate Development /s/ William J. Bussiere, Jr., Attorney-in-fact 2017-10-10